Haste Caused CDC Bird Flu Contamination?

The Centers for Disease Control and Prevention scientist who accidentally leaked H5N1 into a benign strain of avian influenza may have been rushing off to a meeting.

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, AZTAn internal report released yesterday (August 18) by the US Centers for Disease Control and Prevention (CDC) suggests that the researcher responsible for the contamination of a relatively benign H9N2 bird flu strain with the deadly H5N1 was overworked and in a rush to attend a lab meeting, factors that likely contributed to the mistake. The report also notes that the accident most likely occurred in mid-January, though the contamination was not discovered until months later, after US Department of Agriculture (USDA) researchers who had received an H9N2 sample from the CDC reported that their test chickens died. The incident was made public by CDC Director Thomas Frieden in July in the wake of other high-profile lab safety lapses.

The incident is “unacceptable,” CDC’s Anne Schuchat, director of the agency’s National Center for Immunization and Respiratory Diseases, told USA Today. “We just don’t think shortcuts are permissible when working with these kinds of dangerous pathogens.”

According to the report, the researcher did not follow proper decontamination protocols while working with both bird flu strains under the same biosafety cabinet. In addition to a lab meeting at noon that the researcher was rushing to, he or she was also dealing with a “heavy workload” as the group worked to prepare data for a World Health Organization vaccine meeting in February.

The H9N2 sample was sent to the USDA on March 12, and word of the contamination made it back to the CDC on May 23, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies